2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · see citing works

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,712 · see citing works

Contemporary Definitions and Classification of the Cardiomyopathies

Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424 · see citing works

The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction

Kim, R. J., Wu, E., Rafael, A., Chen, E.-L., Parker, M. A., Simonetti, O. P., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432003 · Cited by 3,308 · see citing works

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo

Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244 · see citing works

ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities

Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546 · see citing works

Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults

Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T., & Bild, D. E. (1995) · Circulation · doi:10.1161/01.cir.92.4.785 · Cited by 2,274 · see citing works

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,242 · see citing works

Hypertrophic Cardiomyopathy: A Systematic Review

Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224 · see citing works

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,212 · see citing works

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,105 · see citing works

Sudden Deaths in Young Competitive Athletes

Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,075 · see citing works

Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults: A Scientific Statement From the American Heart Association

Balady, G. J., Arena, R., Sietsema, K., Myers, J., Coke, L., Fletcher, G. F., Forman, D., Franklin, B., Guazzi, M., Gulati, M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181e52e69 · Cited by 1,964 · see citing works

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189742 · Cited by 1,768 · see citing works

Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles

Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693 · see citing works

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572 · see citing works

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,468 · see citing works

Sudden Death in Young Athletes

Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022783 · Cited by 1,394 · see citing works

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,367 · see citing works

Does sports activity enhance the risk of sudden death in adolescents and young adults?

Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., & Thiene, G. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.03.002 · Cited by 1,311 · see citing works

Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy

Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142 · see citing works

Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction

Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., Nistri, S., Cecchi, F., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.106.644682 · Cited by 1,118 · see citing works

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,117 · see citing works

ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS

Teare, D. (1958) · Heart · doi:10.1136/hrt.20.1.1 · Cited by 1,082 · see citing works

The Genetic Basis for Cardiomyopathy

Seidman, J. G., & Seidman, C. E. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,043 · see citing works

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 1,040 · see citing works

The Management of Hypertrophic Cardiomyopathy

Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,026 · see citing works

High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*

Spada, M., Pagliardini, S., Yasuda, M., Tükel, T., Thiagarajan, G., Sakuraba, H., Ponzone, A., & Desnick, R. J. (2006) · The American Journal of Human Genetics · doi:10.1086/504601 · Cited by 1,007 · see citing works

Screening for Hypertrophic Cardiomyopathy in Young Athletes

Corrado, D., Basso, C., Schiavon, M., & Thiene, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390602 · Cited by 994 · see citing works

Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology

Pelliccia, A. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi325 · Cited by 983 · see citing works

Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

Maceira, A. M., Joshi, J., Prasad, S. K., Moon, J., Perugini, E., Harding, I., Sheppard, M. N., Poole-Wilson, P. A., Hawkins, P. N., & Pennell, D. J. (2005) · Circulation · doi:10.1161/01.cir.0000152819.97857.9d · Cited by 982 · see citing works

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients

Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976 · see citing works

Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy

Watkins, H. C., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O'Donoghue, A., Spirito, P., Matsumori, A., Moravec, C. S., Seidman, J. G., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504203321603 · Cited by 935 · see citing works

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 921 · see citing works

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 863 · see citing works

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859 · see citing works

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

Wigle, E. D., Sasson, Z., Henderson, M. A., Ruddy, T. D., Fulop, J. C., Rakowski, H., & Williams, W. G. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(85)90024-6 · Cited by 822 · see citing works

Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy

O’Hanlon, R., Grasso, A. E., Roughton, M., Moon, J., Clark, S., Wage, R., Webb, J., Kulkarni, M., Dawson, D. K., Sulaibeekh, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.010 · Cited by 816 · see citing works

Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy

Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.090 · Cited by 809 · see citing works

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

Sigwart, U. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91267-3 · Cited by 804 · see citing works

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

Maron, B. J., Olivotto, I., Spirito, P., Casey, S. A., Bellone, P., Gohman, T. E., Graham, K. J., Burton, D. A., & Cecchi, F. (2000) · Circulation · doi:10.1161/01.cir.102.8.858 · Cited by 799 · see citing works

Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 798 · see citing works

Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy

Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 776 · see citing works

Hypertrophic Cardiomyopathy

Wigle, E. D., Rakowski, H., Kimball, B. P., & Williams, W. G. (1995) · Circulation · doi:10.1161/01.cir.92.7.1680 · Cited by 775 · see citing works

Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance

Moon, J., McKenna, W. J., McCrohon, J. A., Elliot, P. M., Smith, G. C., & Pennell, D. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00189-x · Cited by 767 · see citing works

Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients

D, E. B. M., Lambrew, C. T., Rockoff, S. D., Ross, J., & Morrow, A. G. (1964) · Circulation · doi:10.1161/01.cir.29.5s4.iv-3 · Cited by 758 · see citing works

Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy

Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H. C., Chudley, A. E., McKenna, W. J., Kristinsson, A., Roberts, R., Sole, M. J., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 757 · see citing works

Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy

Maron, B. J., Wolfson, J. K., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80181-4 · Cited by 754 · see citing works

The Heart of Trained Athletes

Maron, B. J., & Pelliccia, A. (2006) · Circulation · doi:10.1161/circulationaha.106.613562 · Cited by 746 · see citing works

Characteristics and Prognostic Implications of Myosin Missense Mutations in Familial Hypertrophic Cardiomyopathy

Watkins, H. C., Rosenzweig, A., Hwang, D., Levi, T., McKenna, W. J., Seidman, C. E., & Seidman, J. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261703 · Cited by 742 · see citing works

Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy

Pandit, B., Sárközy, A., Pennacchio, L. A., Carta, C., Oishi, K., Martinelli, S., Pogna, E. A., Schackwitz, W., Ustaszewska, A., Landstrom, A. P., et al. (2007) · Nature Genetics · doi:10.1038/ng2073 · Cited by 700 · see citing works

Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy

Ho, C. Y., López, B., Coelho‐Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolı́m, P., Kwong, R. Y. K., González, A., Colan, S. D., Seidman, J. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002659 · Cited by 697 · see citing works

Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

Harris, K. M., Spirito, P., Maron, M. S., Zenovich, A. G., Formisano, F., Lesser, J. R., Mackey‐Bojack, S., Manning, W. J., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.105.583500 · Cited by 665 · see citing works

Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance

Adabag, A. S., Maron, B. J., Appelbaum, E., Harrigan, C. J., Buros, J. L., Gibson, C. M., Lesser, J. R., Hanna, C. A., Udelson, J. E., Manning, W. J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.071 · Cited by 662 · see citing works

Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients

Klues, H. G., Schiffers, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00390-8 · Cited by 653 · see citing works

Glycogen Storage Diseases Presenting as Hypertrophic Cardiomyopathy

Arad, M., Maron, B. J., Gorham, J., Johnson, W. H., Saul, J. P., Pérez‐Atayde, A. R., Spirito, P., Wright, G. B., Kanter, R. J., Seidman, C. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa033349 · Cited by 643 · see citing works

Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years

Kleemann, T., Becker, T., Doenges, K., Vater, M., Senges, J., Schneider, S., Saggau, W., Weisse, U., & Seidl, K. (2007) · Circulation · doi:10.1161/circulationaha.106.663807 · Cited by 633 · see citing works

Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy

Choudhury, L., Mahrholdt, H., Wagner, A., Choi, K. M., Elliott, M. D., Klocke, F. J., Bonow, R. O., Judd, R. M., & Kim, R. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02602-5 · Cited by 627 · see citing works

Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features

McKenna, W. J., Deanfield, J. E., FARUQUI, A. M. A., England, D., Oakley, C. M., & Goodwin, J. F. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90535-x · Cited by 626 · see citing works

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy

Maron, B. J., Gottdiener, J. S., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90068-0 · Cited by 599 · see citing works

Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases

Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayés de Luna, A., Corrado, D., Crosson, J. E., Deal, B. J., Driscoll, D. J., Estes, N. A. M., Araújo, C. G. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128363.85581.e1 · Cited by 591 · see citing works

Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy

Bruder, O., Wagner, A., Jensen, C. J., Schneider, S., Ong, P., Kispert, E.-M., Naßenstein, K., Schlosser, T. W., Sabin, G. V., Sechtem, U. P., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.007 · Cited by 590 · see citing works

Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy

Rickers, C., Wilke, N. M., Jerosch‐Herold, M., Casey, S. A., Panse, P. M., Panse, N., Weil, J., Zenovich, A. G., & Maron, B. J. (2005) · Circulation · doi:10.1161/circulationaha.104.507723 · Cited by 579 · see citing works

Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy

Maron, M. S., Finley, J., Bos, J. M., Hauser, T. H., Manning, W. J., Haas, T. S., Lesser, J. R., Udelson, J. E., Ackerman, M. J., & Maron, B. J. (2008) · Circulation · doi:10.1161/circulationaha.108.781401 · Cited by 566 · see citing works

The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the Literature

van den Hout, H. M. P., Hop, W. J. C., van Diggelen, O. P., Smeitink, J. A. M., Smit, G., Poll‐The, B. T., Bakker, H. D., Loonen, M. C. B., de Klerk, J. B. C., Reuser, A. J. J., et al. (2003) · PEDIATRICS · doi:10.1542/peds.112.2.332 · Cited by 554 · see citing works

Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort

Maron, B. J. (1999) · JAMA · doi:10.1001/jama.281.7.650 · Cited by 553 · see citing works

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy

Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., & McKenna, W. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00827-1 · Cited by 541 · see citing works

Causes of sudden death in competitive athletes

Maron, B. J., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80283-2 · Cited by 536 · see citing works

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.001 · Cited by 527 · see citing works

Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy

Elliot, P. M., Gimeno, J. R., Mahon, N., Poloniecki, J. D., & McKenna, W. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04005-8 · Cited by 517 · see citing works

Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance

Maron, M. S., Maron, B. J., Harrigan, C. J., Buros, J., Gibson, C. M., Olivotto, I., Biller, L. H., Lesser, J. R., Udelson, J. E., Manning, W. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.006 · Cited by 501 · see citing works

Global and Regional Myocardial Function Quantification by Two-Dimensional Strain

Serri, K., Réant, P., Lafitte, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.061 · Cited by 497 · see citing works

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study

Maron, B. J., Savage, D. D., Wolfson, J. K., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90604-4 · Cited by 494 · see citing works

Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

Maron, B. J., Nishimura, R. A., McKenna, W. J., Rakowski, H., Josephson, M. E., & Kieval, R. S. (1999) · Circulation · doi:10.1161/01.cir.99.22.2927 · Cited by 490 · see citing works

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

Cannon, R. O., Rosing, D. R., Maron, B. J., et al. (1985) · Circulation · doi:10.1161/01.cir.71.2.234 · Cited by 478 · see citing works

Long-term outcome in patients with apical hypertrophic cardiomyopathy

Eriksson, M. J., Sonnenberg, B., Woo, A., Rakowski, P., Parker, T. G., Wigle, E. D., & Rakowski, H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01778-8 · Cited by 476 · see citing works

Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children

Colan, S. D., Lipshultz, S. E., Lowe, A. M., Sleeper, L. A., Messere, J. E., Cox, G. F., Lurie, P. R., Orav, E. J., & Towbin, J. A. (2007) · Circulation · doi:10.1161/circulationaha.106.621185 · Cited by 472 · see citing works

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease Evidence for a disease specific abnormality of the myocardial interstitium

Moon, J. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.017 · Cited by 469 · see citing works

Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease

Scaglia, F., Towbin, J. A., Craigen, W. J., Belmont, J. W., Smith, E. O., Neish, S. R., Ware, S. M., Hunter, J. V., Fernbach, S. D., Vladutiu, G. D., et al. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0718 · Cited by 463 · see citing works

Hypertrophie cardiomyopathy: A discussion of nomenclature

Maron, B. J., & Epstein, S. E. (1979) · The American Journal of Cardiology · doi:10.1016/0002-9149(79)90160-7 · Cited by 442 · see citing works

Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography

Moon, J., Fisher, N. G., McKenna, W. J., et al. (2004) · Heart · doi:10.1136/hrt.2003.014969 · Cited by 441 · see citing works

Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy

Elliot, P. M., Gimeno, J. R., Tome, M., Shah, J., Ward, D., Thaman, R., Mogensen, J., & McKenna, W. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl041 · Cited by 428 · see citing works

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy

Driest, S. L. V., Vasile, V. C., Ommen, S. R., Will, M. L., Tajik, A. J., Gersh, B. J., & Ackerman, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.045 · Cited by 423 · see citing works

ACC/AHA/SCAI Practice Guidelines, February 21, 2006

(2006) · Circulation · doi:10.1161/circulationaha.106.173220 · Cited by 422 · see citing works

Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy

Ho, C. Y., Sweitzer, N. K., McDonough, B. A., Maron, B. J., Casey, S. A., Seidman, J. G., Seidman, C. E., & Solomon, S. D. (2002) · Circulation · doi:10.1161/01.cir.0000019070.70491.6d · Cited by 420 · see citing works

Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy

Rubinshtein, R., Glockner, J. F., Ommen, S. R., Araoz, P. A., Ackerman, M. J., Sorajja, P., Bos, J. M., Tajik, A. J., Valeti, U. S., Nishimura, R. A., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.854026 · Cited by 418 · see citing works

Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy

Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.012 · Cited by 410 · see citing works

Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults

Morita, H., Rehm, H. L., Menesses, A., McDonough, B. A., Roberts, A. E., Kucherlapati, R., Towbin, J. A., Seidman, J. G., & Seidman, C. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075463 · Cited by 404 · see citing works

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

Maron, B. J., Olivotto, I., Bellone, P., Conte, M. R., Cecchi, F., Flygenring, B., Casey, S. A., Gohman, T. E., Bongioanni, S., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01727-2 · Cited by 396 · see citing works

Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.

Bonow, R. O., Rosing, D. R., Bacharach, S. L., Green, M. V., Kent, K. M., Lipson, L. C., Maron, B. J., Leon, M. B., & Epstein, S. E. (1981) · Circulation · doi:10.1161/01.cir.64.4.787 · Cited by 393 · see citing works

Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy

Bos, J. M., Towbin, J. A., & Ackerman, M. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.075 · Cited by 392 · see citing works

Cardiac Disease in Young Trained Athletes

Maron, B. J., Pelliccia, A., & Spirito, P. (1995) · Circulation · doi:10.1161/01.cir.91.5.1596 · Cited by 387 · see citing works

Sudden Death due to Troponin T Mutations

Moolman, J. C., Corfield, V. A., Posen, B., Ngumbela, K. C., Seidman, C. E., Brink, P. A., & Watkins, H. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00530-x · Cited by 387 · see citing works

Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

Ingles, J., Doolan, A., Chiu, C., Seidman, J. G., Seidman, C. E., & Semsarian, C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033886 · Cited by 385 · see citing works

Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics

Alcalai, R., Seidman, J. G., & Seidman, C. E. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00965.x · Cited by 381 · see citing works

Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy

Olivotto, I., Girolami, F., Ackerman, M. J., Nistri, S., Bos, J. M., Zachara, E., Ommen, S. R., Theis, J. L., Vaubel, R. A., Re, F., et al. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.6.630 · Cited by 380 · see citing works

Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.

Fananapazir, L., Epstein, N. D., Curiel, R., Panza, J. A., Tripodi, D., & McAreavey, D. (1994) · Circulation · doi:10.1161/01.cir.90.6.2731 · Cited by 380 · see citing works

Dual-Chamber Pacing for Hypertrophic Cardiomyopathy: A Randomized, Double-Blind, Crossover Trial

Nishimura, R. A., Trusty, J. M., Hayes, D. L., Ilstrup, D. M., Larson, D. R., Hayes, S. N., Allison, T. G., & Tajik, A. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00473-1 · Cited by 376 · see citing works

Syncope and risk of sudden death in hypertrophic cardiomyopathy

Spirito, P., Autore, C., Rapezzi, C., Bernabò, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N. A. M., Barillà, C. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.798314 · Cited by 365 · see citing works

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary

Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189741 · Cited by 363 · see citing works

Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy.

Klues, H. G., Maron, B. J., Dollar, A. L., & Roberts, W. C. (1992) · Circulation · doi:10.1161/01.cir.85.5.1651 · Cited by 361 · see citing works

Side effects of long-term amiodarone therapy.

Harris, L., McKenna, W. J., Rowland, E., Holt, D. W., Storey, G., & KRIKLER, D. M. (1983) · Circulation · doi:10.1161/01.cir.67.1.45 · Cited by 358 · see citing works

[Guidelines for the management of patients with atrial fibrillation. Executive summary].

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · PubMed · Cited by 356 · see citing works

Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy

Patel, R., Nagueh, S. F., Tsybouleva, N., Abdellatif, M., Lutucuta, S., Kopelen, H. A., Quiñones, M. A., Zoghbi, W. A., Entman, M. L., Roberts, R., et al. (2001) · Circulation · doi:10.1161/hc2801.094031 · Cited by 353 · see citing works

Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy

Faber, L., Seggewiß, H., & Gleichmann, U. (1998) · Circulation · doi:10.1161/01.cir.98.22.2415 · Cited by 349 · see citing works

Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy

Maron, B. J. (2009) · JAMA · doi:10.1001/jama.2009.371 · Cited by 343 · see citing works

Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography

Camici, P. G., Chiriatti, G., Lorenzoni, R., Bellina, R. C., Gistri, R., Italiani, G., Parodi, O., Salvadori, P. A., Nista, N., Papi, L., et al. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90869-b · Cited by 338 · see citing works

Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy

Woo, A., Williams, W. G., Choi, R., Wigle, E. D., Rozenblyum, E., Fedwick, K., Siu, S. C., Ralph-Edwards, A. C., & Rakowski, H. (2005) · Circulation · doi:10.1161/01.cir.0000162460.36735.71 · Cited by 334 · see citing works

Prospective Prognostic Assessment of Blood Pressure Response During Exercise in Patients With Hypertrophic Cardiomyopathy

Sadoul, N., Prasad, K., Elliot, P. M., Bannerjee, S., Frenneaux, M. P., & McKenna, W. J. (1997) · Circulation · doi:10.1161/01.cir.96.9.2987 · Cited by 331 · see citing works

Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy

Geske, J. B., Sorajja, P., Nishimura, R. A., & Ommen, S. R. (2007) · Circulation · doi:10.1161/circulationaha.107.698985 · Cited by 328 · see citing works

Evaluation of Patients With Severe Symptomatic Aortic Stenosis Who Do Not Undergo Aortic Valve Replacement: The Potential Role of Subjectively Overestimated Operative Risk

Bach, D. S., Siao, D., Girard, S. E., Duvernoy, C., McCallister, B. D., & Gualano, S. K. (2009) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.848259 · Cited by 327 · see citing works

Clinical Course and Prognosis of Hypertrophic Cardiomyopathy in an Outpatient Population

Spirito, P., Chiarella, F., Carratino, L., Berisso, M. Z., Bellotti, P., & Vecchio, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903233201201 · Cited by 326 · see citing works

Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy

Jeanrenaud, X., Goy, J., & KAPPENBERGER, L. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)91961-7 · Cited by 324 · see citing works

Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies

Bourassa, M. G., Butnaru, A., Lespérance, J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02768-7 · Cited by 323 · see citing works

Hypertrophic Obstructive Cardiomyopathy

Nishimura, R. A., & Holmes, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp030779 · Cited by 319 · see citing works

Recommendations for reducing radiation exposure in myocardial perfusion imaging

Cerqueira, M. D., Allman, K. C., Ficaro, E. P., et al. (2010) · Journal of Nuclear Cardiology · doi:10.1007/s12350-010-9244-0 · Cited by 313 · see citing works

Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis).

Brock, R. (1957) · PubMed · Cited by 309 · see citing works

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.025 · Cited by 307 · see citing works

The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy

Maron, M. S., Olivotto, I., Maron, B. J., Prasad, S. K., Cecchi, F., Udelson, J. E., & Camici, P. G. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.072 · Cited by 306 · see citing works

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy

Maron, B. J., Carney, K. P., Lever, H. M., Lewis, J. F., Barač, I., Casey, S. A., & Sherrid, M. V. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02976-5 · Cited by 305 · see citing works

THE GENETIC BASIS FOR CARDIAC REMODELING

Ahmad, F., Seidman, J. G., & Seidman, C. E. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162132 · Cited by 305 · see citing works

Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

Sorajja, P., Valeti, U. S., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Hodge, D. O., Schaff, H. V., & Holmes, D. R. (2008) · Circulation · doi:10.1161/circulationaha.107.738740 · Cited by 303 · see citing works

Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy

Sherrid, M. V., Gunsburg, D. Z., Moldenhauer, S., & Pearle, G. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00830-5 · Cited by 297 · see citing works

Hypertrophic cardiomyopathy in tuscany: Clinical course and outcome in an unselected regional population

Cecchi, F., Olivotto, I., Montereggi, A., Santoro, G., Dolara, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00353-3 · Cited by 296 · see citing works

Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults

Zou, Y., Song, L., Wang, Z., Ma, A., Liu, T., Gu, H., Lu, S., Peng-zhu, W., Zhang, †. Y., Shen, †. L., et al. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.05.009 · Cited by 296 · see citing works

Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations Revisited

Pelliccia, A., Zipes, D. P., & Maron, B. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.055 · Cited by 295 · see citing works

Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations

Girolami, F., Ho, C. Y., Semsarian, C., Baldi, M., Will, M. L., Baldini, K., Torricelli, F., Yeates, L., Cecchi, F., Ackerman, M. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.062 · Cited by 295 · see citing works

Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study

KAPPENBERGER, L. J., Linde, C. M., Daubert, C., McKenna, W. J., Meisel, E., Sadoul, N., Chojnowska, L., Guize, L., Gras, D., Jeanrenaud, X., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015435 · Cited by 295 · see citing works

Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy

Maron, M. S., Appelbaum, E. A., Harrigan, C. J., Buros, J., Gibson, C. M., Hanna, C., Lesser, J. R., Udelson, J. E., Manning, W. J., & Maron, B. J. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.768119 · Cited by 295 · see citing works

Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

Maron, B. J. (2010) · Circulation · doi:10.1161/circulationaha.109.878579 · Cited by 295 · see citing works

Atrial fibrillation in hypertrophie cardiomyopathy: A longitudinal study

Robinson, K., Frenneaux, M. P., Stockins, B., Karatasakis, G., Poloniecki, J. D., & McKenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80014-2 · Cited by 294 · see citing works

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.

Fananapazir, L., Cannon, R. O., Tripodi, D., & Panza, J. A. (1992) · Circulation · doi:10.1161/01.cir.85.6.2149 · Cited by 292 · see citing works

Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy

Monserrat, L., Gimeno, J. R., Marín, F. R., Hermida‐Prieto, M., García‐Honrubia, A., Pérez, I., Fernández, X., de Nicolás, R., de la Morena, G., Payá, E., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.062 · Cited by 291 · see citing works

Surgical Treatment of Idiopathic Hypertrophic Subaortic Stenosis

Morrow, A. G., & Brockenbrough, E. C. (1961) · Annals of Surgery · doi:10.1097/00000658-196108000-00003 · Cited by 287 · see citing works

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Anan, R., Greve, G., Thierfelder, L., Watkins, H. C., McKenna, W. J., Solomon, S. D., Vecchio, C., Shono, H., Nakao, S., & Tanaka, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116957 · Cited by 285 · see citing works

Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.

Frenneaux, M. P., Counihan, P. J., Caforio, A. L. P., Chikamori, T., & McKenna, W. J. (1990) · Circulation · doi:10.1161/01.cir.82.6.1995 · Cited by 282 · see citing works

Morning increase in platelet aggregability. Association with assumption of the upright posture.

Brezinski, D. A., Tofler, G. H., Muller, J. E., Pohjola‐Sintonen, S., Willich, S. N., Schafer, A. I., Czeisler, C. A., & Williams, G. H. (1988) · Circulation · doi:10.1161/01.cir.78.1.35 · Cited by 282 · see citing works

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article : A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines

Smith, S. J. (2006) · Journal of the American College of Cardiology · Cited by 280 · see citing works

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy

Dilsizian, V., Bonow, R. O., Epstein, S. E., & Fananapazir, L. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90193-5 · Cited by 276 · see citing works

Updated Meta-Analysis of Septal Alcohol Ablation Versus Myectomy for Hypertrophic Cardiomyopathy

Agarwal, S., Tuzcu, E. M., Desai, M. Y., Smedira, N. G., Lever, H. M., Lytle, B. W., & Kapadia, S. R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.047 · Cited by 276 · see citing works

Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease

Nagueh, S. F., McFalls, J., Meyer, D., Hill, R., Zoghbi, W. A., Tam, J. W., Quiñones, M. A., Roberts, R., & Marian, A. J. (2003) · Circulation · doi:10.1161/01.cir.0000084500.72232.8d · Cited by 275 · see citing works

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

Semsarian, C., Ahmad, I., Giewat, M., Georgakopoulos, D., Schmitt, J. P., McConnell, B. K., Reiken, S. R., Mende, U., Marks, A. R., Kass, D. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14677 · Cited by 275 · see citing works

Current Effectiveness and Risks of Isolated Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy

Smedira, N. G., Lytle, B. W., Lever, H. M., et al. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.07.063 · Cited by 274 · see citing works

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy

Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.043 · Cited by 273 · see citing works

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.

Epstein, S. E., & Rosing, D. R. (1981) · Circulation · doi:10.1161/01.cir.64.3.437 · Cited by 272 · see citing works

Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

Bonow, R. O., Dilsizian, V., Rosing, D. R., et al. (1985) · Circulation · doi:10.1161/01.cir.72.4.853 · Cited by 272 · see citing works

The "Duty to Warn" a Patient's Family Members About Hereditary Disease Risks

Offit, K. (2004) · JAMA · doi:10.1001/jama.292.12.1469 · Cited by 270 · see citing works

Prevalence of Fabry Disease in Female Patients With Late-Onset Hypertrophic Cardiomyopathy

Chimenti, C., Pieroni, M., Morgante, E., Antuzzi, D., Russo, A., Russo, M. A., Maseri, A., & Frustaci, A. (2004) · Circulation · doi:10.1161/01.cir.0000139847.74101.03 · Cited by 269 · see citing works

Myocardial Bridging in Children with Hypertrophic Cardiomyopathy — A Risk Factor for Sudden Death

Yetman, A. T., McCrindle, B. W., MacDonald, C., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391704 · Cited by 268 · see citing works

Functional, angiographic and intracoronary doppler flow characteristics in symptomatic patients with myocardial bridging: Effect of short-term intravenous beta-blocker medication

Schwarz, E. R., Klues, H. G., Dahl, J. V., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00062-9 · Cited by 268 · see citing works

Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome

Maron, B. J., Ackerman, M. J., Nishimura, R. A., Pyeritz, R. E., Towbin, J. A., & Udelson, J. E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.011 · Cited by 265 · see citing works

Natural History of Hypertrophic Cardiomyopathy

Cannan, C. R., Reeder, G. S., Bailey, K. R., Melton, L. J., & Gersh, B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.2488 · Cited by 265 · see citing works

Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.

O’Gara, P. T., Bonow, R. O., Maron, B. J., Damske, B. A., van Lingen, A., Bacharach, S. L., Larson, S. M., & Epstein, S. E. (1987) · Circulation · doi:10.1161/01.cir.76.6.1214 · Cited by 265 · see citing works

Meta-analysis: Noninvasive Coronary Angiography Using Computed Tomography Versus Magnetic Resonance Imaging

Schuetz, G. M., Zacharopoulou, N. M., Schlattmann, P., & Dewey, M. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-3-201002020-00008 · Cited by 263 · see citing works

Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction.

Klues, H. G., Roberts, W. C., & Maron, B. J. (1991) · Circulation · doi:10.1161/01.cir.84.3.1188 · Cited by 262 · see citing works

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.

Fananapazir, L., Chang, A. C., Epstein, S. E., & McAreavey, D. (1992) · Circulation · doi:10.1161/01.cir.86.3.730 · Cited by 259 · see citing works

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

Elliot, P. M., Sharma, S., Varnava, A. M., Poloniecki, J. D., Rowland, E., & McKenna, W. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00056-x · Cited by 257 · see citing works

Prognostic Significance of Left Atrial Size in Patients With Hypertrophic Cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)

Nistri, S., Olivotto, I., Betocchi, S., Losi, M. A., Valsecchi, G., Pinamonti, B., Conte, M. R., Casazza, F., Galderisi, M., Maron, B. J., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.05.013 · Cited by 257 · see citing works

STUDIES ON DIGITALIS. IV. OBSERVATIONS IN MAN ON THE EFFECTS OF DIGITALIS PREPARATIONS ON THE CONTRACTILITY OF THE NON-FAILING HEART AND ON TOTAL VASCULAR RESISTANCE

D, E. B. M., Bloodwell, R. D., Goldberg, L. I., et al. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104236 · Cited by 257 · see citing works

Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis

Friedman, P. A., McClelland, R. L., Bamlet, W. R., Acosta, H., Kessler, D. J., Munger, T. M., Kavesh, N. G., Wood, M., Daoud, E. G., Massumi, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594531 · Cited by 255 · see citing works

The 50-Year History, Controversy, and Clinical Implications of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy

Maron, B. J., Maron, M. S., Wigle, E. D., & Braunwald, E. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.069 · Cited by 255 · see citing works

Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy

Olivotto, I., Maron, B. J., Montereggi, A., Mazzuoli, F., Dolara, A., & Cecchi, F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00094-7 · Cited by 254 · see citing works

Association Between Regional Ventricular Function and Myocardial Fibrosis in Hypertrophic Cardiomyopathy Assessed by Speckle Tracking Echocardiography and Delayed Hyperenhancement Magnetic Resonance Imaging

Popović, Z., Kwon, D. H., Mishra, M., Buakhamsri, A., Greenberg, N. L., Thamilarasan, M., Flamm, S. D., Thomas, J. D., Lever, H. M., & Desai, M. Y. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.09.011 · Cited by 252 · see citing works

Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy

Olivotto, I., Cecchi, F., Gistri, R., Lorenzoni, R., Chiriatti, G., Girolami, F., Torricelli, F., & Camici, P. G. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.050 · Cited by 249 · see citing works

Do Current Dual Chamber Cardioverter Defibrillators Have Advantages Over Conventional Single Chamber Cardioverter Defibrillators in Reducing Inappropriate Therapies? A Randomized, Prospective Study

Deisenhofer, I., Kolb, C., Ndrepepa, G., et al. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00134.x · Cited by 248 · see citing works

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.

Rosing, D. R., Kent, K. M., Maron, B. J., & Epstein, S. E. (1979) · Circulation · doi:10.1161/01.cir.60.6.1208 · Cited by 244 · see citing works

Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy

Nagueh, S. F., Ommen, S. R., Lakkis, N. M., Killip, D., Zoghbi, W. A., Schaff, H. V., Danielson, G. K., Quiñones, M. A., Tajik, A. J., & Spencer, W. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01614-x · Cited by 240 · see citing works

Effects of Beta Adrenergic Blockade on the Circulation, with Particular Reference to Observations in Patients with Hypertrophic Subaortic Stenosis

Harrison, D. C., D, E. B. M., Glick, G., Mason, D. T., Chidsey, C. A., & Ross, J. (1964) · Circulation · doi:10.1161/01.cir.29.1.84 · Cited by 239 · see citing works

Echocardiography-Guided Genetic Testing in Hypertrophic Cardiomyopathy: Septal Morphological Features Predict the Presence of Myofilament Mutations

Binder, J. S., Ommen, S. R., Gersh, B. J., Driest, S. L. V., Tajik, A. J., Nishimura, R. A., & Ackerman, M. J. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.459 · Cited by 236 · see citing works

Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin t genes in hypertrophic cardiomyopathy

Ackerman, M. J., VanDriest, S. L., Ommen, S. R., Will, M. L., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01900-9 · Cited by 235 · see citing works

Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision making

Grigg, L., Wigle, E. D., Williams, W. G., Daniel, L. B., & Rakowski, H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90135-a · Cited by 234 · see citing works

Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations

Maron, B. J., Niimura, H., Casey, S. A., Soper, M. K., Wright, G. B., Seidman, J. G., & Seidman, C. E. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01386-9 · Cited by 234 · see citing works

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

Semsarian, C., Ahmad, I., Giewat, M., Georgakopoulos, D., Schmitt, J. P., McConnell, B. K., Reiken, S. R., Mende, U., Marks, A. R., Kass, D. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214677 · Cited by 233 · see citing works

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.

Rosing, D. R., Kent, K. M., Borer, J. S., et al. (1979) · Circulation · doi:10.1161/01.cir.60.6.1201 · Cited by 232 · see citing works

Comparison of Surgical Septal Myectomy and Alcohol Septal Ablation With Cardiac Magnetic Resonance Imaging in Patients With Hypertrophic Obstructive Cardiomyopathy

Valeti, U. S., Nishimura, R. A., Holmes, D. R., Araoz, P. A., Glockner, J. F., Breen, J. F., Ommen, S. R., Gersh, B. J., Tajik, A. J., Rihal, C. S., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.055 · Cited by 231 · see citing works

Echocardiography-Guided Ethanol Septal Reduction for Hypertrophic Obstructive Cardiomyopathy

Lakkis, N. M., Nagueh, S. F., Kleiman, N. S., Killip, D., He, Z., Verani, M. S., Roberts, R., & Spencer, W. H. (1998) · Circulation · doi:10.1161/01.cir.98.17.1750 · Cited by 230 · see citing works

Extent of Clinical Improvement After Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy

McCully, R. B., Nishimura, R. A., Tajik, A. J., Schaff, H. V., & Danielson, G. K. (1996) · Circulation · doi:10.1161/01.cir.94.3.467 · Cited by 229 · see citing works

Muscular Subaortic Stenosis

Pollick, C. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210143071607 · Cited by 229 · see citing works

Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae

Minakata, K., Dearani, J. A., Nishimura, R. A., et al. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.09.040 · Cited by 228 · see citing works

Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy

Yu, E., Omran, A., Wigle, E. D., Williams, W. G., Siu, S. C., & Rakowski, H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01019-6 · Cited by 226 · see citing works

Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy

Gietzen, F. H. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1520 · Cited by 223 · see citing works

Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death

McKenna, W. J., & Behr, E. R. (2002) · Heart · doi:10.1136/heart.87.2.169 · Cited by 222 · see citing works

To the Editor

Stöllberger, C., Pfersmann, V., & Finsterer, J. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.01.020 · Cited by 222 · see citing works

Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy

Robbins, R. C., & Stinson, E. B. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70310-0 · Cited by 219 · see citing works

Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs∗

D, E. B. M., & Ebert, P. A. (1962) · The American Journal of Cardiology · doi:10.1016/0002-9149(62)90373-9 · Cited by 217 · see citing works

Predictors of sudden cardiac death in hypertrophic cardiomyopathy

Maki, S., Ikeda, H., Muro, A., Yoshida, N., Shibata, A., Koga, Y., & Imaizumi, T. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00455-x · Cited by 216 · see citing works

Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography

Kato, T. S., Noda, A., Izawa, H., et al. (2004) · Circulation · doi:10.1161/01.cir.0000150334.69355.00 · Cited by 216 · see citing works

Progress With Genetic Cardiomyopathies

Hershberger, R. E., Cowan, J. R., Morales, A., & Siegfried, J. D. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.817346 · Cited by 216 · see citing works

Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil

Bonow, R. O., Frederick, T. M., Bacharach, S. L., et al. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90317-x · Cited by 216 · see citing works

Systolic Myocardial Mechanics in Hypertrophic Cardiomyopathy: Novel Concepts and Implications for Clinical Status

Carasso, S., Yang, H., Woo, A., Vannan, M. A., Jamorski, M., Wigle, E. D., & Rakowski, H. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.10.021 · Cited by 215 · see citing works

The case for surgery in obstructive hypertrophic cardiomyopathy

Maron, B. J., Dearani, J. A., Ommen, S. R., Maron, M. S., Schaff, H. V., Gersh, B. J., & Nishimura, R. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.063 · Cited by 215 · see citing works

Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery11Supported, in part, by grant NCC9-60 from the National Aeronautics and Space Administration, Houston, Texas, Grant #9951522V from the America Heart Association Ohio Local Chapter, Columbus, Ohio and Grant #R01 HL56688-01A1 from the National Institutes of Health, Bethesda, Maryland.22Presented, in part, at the 49th Annual Scientific Sessions of American College of Cardiology, March 2000, Anaheim, California.

Xin, J., Shiota, T., Lever, H. M., Kapadia, S. R., Sitges, M., Rubin, D. N., Bauer, F., Greenberg, N. L., Agler, D. A., Drinko, J. K., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01656-4 · Cited by 211 · see citing works

Long-Term Outcome of Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy

ten Cate, F. J., Soliman, O. I. I., Michels, M., Theuns, D. A. M. J., de Jong, P. L., Geleijnse, M. L., & Serruys, P. W. J. C. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.862359 · Cited by 211 · see citing works

Recalls and Safety Alerts Involving Pacemakers and Implantable Cardioverter-Defibrillator Generators

Maisel, W. H. (2001) · JAMA · doi:10.1001/jama.286.7.793 · Cited by 210 · see citing works

Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy

Gimeno, J. R., Tome, M., Lofiego, C., Hurtado, J., Pantazis, A. A., Mist, B., Lambiase, P. D., McKenna, W. J., & Elliot, P. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp327 · Cited by 209 · see citing works

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.

Spirito, P., Rapezzi, C., Autore, C., Bruzzi, P., Bellone, P., Ortolani, P., Fragola, P. V., Chiarella, F., Zoni-Berisso, M., & Branzi, A. (1994) · Circulation · doi:10.1161/01.cir.90.6.2743 · Cited by 204 · see citing works

Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic Blockade

Cohen, L. S., & D, E. B. M. (1967) · Circulation · doi:10.1161/01.cir.35.5.847 · Cited by 203 · see citing works

Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy

McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W.-K., Dearani, J. A., Schaff, H. V., Tajik, A. J., & Gersh, B. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm117 · Cited by 203 · see citing works

Risk associated with pregnancy in hypertrophic cardiomyopathy

Autore, C., Conte, M. R., Piccininno, M., Bernabò, P., Bonfiglio, G., Bruzzi, P., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02495-6 · Cited by 199 · see citing works

Utility of continuous wave doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy

Panza, J. A., Petrone, R. K., Fananapazir, L., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90057-t · Cited by 199 · see citing works

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536 · see citing works

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595 · see citing works

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523 · see citing works

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304 · see citing works

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955 · see citing works

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000040 · Cited by 2,056 · see citing works

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O'Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.537 · Cited by 1,642 · see citing works

ClinGen — The Clinical Genome Resource

Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496 · see citing works

Fully Automated Echocardiogram Interpretation in Clinical Practice: Feasibility and Diagnostic Accuracy

Zhang, J., Gajjala, S., Agrawal, P., Tison, G. H., Hallock, L. A., Beussink-Nelson, L., Lassen, M. H., Fan, E., Aras, M. A., Jordan, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034338 · Cited by 1,006 · see citing works

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay

Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.044 · Cited by 1,008 · see citing works

2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure

Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676 · see citing works

Hypertrophic Cardiomyopathy

Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652 · see citing works

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.004 · Cited by 484 · see citing works

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia

Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.856 · Cited by 439 · see citing works

Detection of hypertrophic cardiomyopathy using a convolutional neural network-enabled electrocardiogram

Ko, W.-Y., Siontis, K. C., Attia, Z. I., Carter, R. E., Kapa, S., Ommen, S. R., Demuth, S. J., Ackerman, M. J., Gersh, B. J., Arruda-Olson, A. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.030 · Cited by 404 · see citing works

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary

Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.043 · Cited by 337 · see citing works

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.003 · Cited by 327 · see citing works

2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry

Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303 · see citing works

2020 ACC/AHA guideline for the management of patients with valvular heart disease

Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279 · see citing works

Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018

Fanaroff, A. C., Califf, R. M., Windecker, S., Smith, S. C., & Lopes, R. D. (2019) · JAMA · doi:10.1001/jama.2019.1122 · Cited by 228 · see citing works

Automated and interpretable patient ECG profiles for disease detection, tracking, and discovery

Tison, G. H., Zhang, J., Delling, F. N., & Deo, R. C. (2019) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005289 · Cited by 208 · see citing works

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary

Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.002 · Cited by 155 · see citing works

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay

Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2018.10.037 · Cited by 131 · see citing works

Impact of ethnicity on cardiac adaptation to exercise

Sheikh, N., & Sharma, S. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.15 · Cited by 44 · see citing works

Prognostic significance of ambulatory ECG monitoring for ventricular arrhythmias

Katritsis, D. G., Siontis, G. C. M., & Camm, A. J. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.07.005 · Cited by 44 · see citing works

Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy

FRANCIA, P., SANTINI, D., MUSUMECI, B., SEMPRINI, L., ADDUCI, C., PAGANNONE, E., PROIETTI, G., VOLPE, M., & AUTORE, C. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12492 · Cited by 34 · see citing works

Phenotype–Genotype Correlation in Hypertrophic Cardiomyopathy: Less Signal, More Noise?

Tower-Rader, A., & Desai, M. Y. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.117.006066 · Cited by 13 · see citing works

ФОРМИРОВAНИЕ ГОТОВНОСТИ БУДУЩИХ ПЕДAГОГОВ К ОРГAНИЗAЦИИ РAБОТЫ ПО РAЗВИТИЮ ВAЛЕОЛОГИЧЕСКОЙ КУЛЬТУРЫ ШКОЛЬНИКОВ

БАЗАРБАЕВА, Ә. А., Майгельдиева, Ш. М., & ЖҮНДІБАЕВА, Т. Н. (2023) · Pedagogy and Psychology · doi:10.51889/2077-6861.2023.1.30.016

चितलवाना पंचायत समिति में मानव गरीबी सूचकांक - 2016 ( à¤à¤• गà¥à¤°à¤¾à¤® सà¥à¤¤à¤°à¥€à¤¯ à¤à¥Œà¤—ोलिक अधà¥à¤¯à¤¯à¤¨ )

Gaurav, S. K., & Swarnkar, P. (2017) · International research journal of multidisciplinary studies

FEATURES AND DIFFERENCES OF ADEQUATE AND EQUIVALENT TRANSLATION

Кенжебaевa, У., Nadirova, G. E., & Seitmetova, Z. (2018) · DOAJ (DOAJ: Directory of Open Access Journals)

Коммуникaтивно- прaгмaтический aнaлиз дипломaтических бумaг (нa основе вербaльных нот)

Кaмирдиновa, Н., & Кaлиевa, Ш. С. (2018) · DOAJ (DOAJ: Directory of Open Access Journals)

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141